Close Menu

NEW YORK (360Dx) – Beckman Coulter Diagnostics said on Wednesday that it has received CE marking for its Early Sepsis Indicator, a hematology test designed to alert emergency department clinicians to the risk of their patients developing sepsis.

The firm is offering the early sepsis indicator as part of a routine complete blood count with differential test. It gives physicians "a rapid and simple tool" that can aid in the fight against sepsis, Beckman said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.

Sponsored by

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.